Guy Rouleau news
Hynes Convention Center - Boston Jumpstarting Neurological Research through Open Science – MNI & McGill University Friday, February 17, 2017, 1:30-2:30 PM/ Room 208
Scientists have identified a gene in the French-Canadian population that predisposes them to the development of intracranial aneurysm (IA), a potentially life threatening neurological condition that is responsible for approximately 500,000 deaths worldwide per year, half of which occur in people less than 50 years of age. Using genetic analysis, the team of researchers found rare variations of one gene, RNF213, that appeared more frequently in IA patients than in the control group. Both patients and the control group came from French-Canadian families.
You probably know someone who has it. It is the most common movement disorder, yet most people don’t even know its name. Essential tremor affects nearly one per cent of the world’s population, increasing to four per cent of those over 40. The involuntary shaking of hands is the most common symptom, but symptoms can also include shaking of the head and legs.
Dr. Guy Rouleau, Director of the Montreal Neurological Institute and Hospital at McGill University and the McGill University Health Centre, has been chosen to receive another major award recognizing his outstanding scientific career. The national organization representing Canadian francophone doctors, Médecins francophones du Canada, is bestowing on him its 2016 Prix de l’oeuvre scientifique.
The Neuro’s director, Dr. Guy Rouleau, has received yet another honour in recognition of his sterling scientific career. The Royal Society of Canada (RSC) announced on Sept. 7 that its members had elected Dr. Rouleau as one of its new Fellows. He joins a currently active membership of more than 2,000 highly distinguished scientists, scholars and artists who nominate and elect up to 75 new members each year.
The Montreal Neurological Institute and Hospital (the Neuro) in Canada to conduct a radical experiment in open science. Nature
By Shawn Hayward, Montreal Neurological Institute and Hospital Discovery will aid development of treatments for this debilitating disease Scientists at the Montreal Neurological Institute and Hospital (MNI) have identified novel gene mutations that cause hereditary spastic paraplegia (HSP), a step forward in efforts to treat this debilitating disease.
Amyotrophic lateral sclerosis (ALS), also known as “Lou Gehrig’s Disease,” is a devastating fatal disease of the nervous system that kills two to five Canadians every day. On September 19th and 20th, the Montreal Neurological Institute and Hospital (The Neuro), at McGill University and the McGill University Health Centre will host the 10th Annual ALS Symposium of the Fondation André-Delambre. Nearly one hundred researchers and clinicians from several countries will come together to discuss recent progress in ALS research.
An international team of researchers has discovered a significant genetic component of Idiopathic Generalized Epilepsy (IGE), the most common form of epilepsy. Epilepsy is a neurological disorder characterized by sudden, uncontrolled electrical discharges in the brain expressed as a seizure.
Dr. Guy Rouleau, Director of the Montreal Neurological Institute and Hospital -The Neuro, at McGill University and McGill University Health Centre, is being awarded the Prix d’excellence 2014 by the Collège des médecins du Québec, for his outstanding contributions to neurogenetics and medicine. Dr. Rouleau accepts the award today at a ceremony at the Chateau Frontenac in Quebec City. TRIBUTE VIDEO: http://bit.ly/1np0tJH
November 8 2012 - After a worldwide search, the renowned Montreal Neurological Institute and Hospital – The Neuro – of McGill University and the McGill University Health Centre has a new director, Guy Rouleau, MD, PhD, FRCPC, OQ. Dr. Rouleau, a prominent Quebec clinician-scientist recognized for his contributions to science and society, will also hold the Wilder Penfield Chair in Neuroscience as Professor of Neurology and Neurosurgery at McGill.
“The Neuro is a tremendous asset to Quebec that contributes directly to the advancement of science and health on a regional and international scale,” said Prof. Heather Munroe-Blum, Principal and Vice-Chancellor of McGill. “It plays a pivotal role in expanding our basic knowledge of the neurosciences, and applying this knowledge to the diagnosis and treatment of neurological disease and the improvement of countless lives in this province and beyond. With the appointment of Dr. Rouleau, we look forward with great confidence to building on the Neuro’s global reputation.”